Tokyo, Oct. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063310) titled 'Constipation Management Insights and Trend' on Oct. 16.
Study Type:
Observational
Primary Sponsor:
Institute - EA Pharma Co.,Ltd.
Condition:
Condition - chronic constipation
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aimed to evaluate temporal changes in the use of medications for constipation treatment in Japan and to investigate whether outcomes of constipation management, including the proportion of stimulant laxative use, enema utilization rates, and manual disimpaction rates, have changed over time.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with a diagnosis of constipation recorded in the JMDC (Japan Medical Data Center) health insurance claims database between 2005 and 2025.
Key exclusion criteria - None
Target Size - 800000
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 09 Month 30 Day
Date of IRB - 2026 Year 10 Month 15 Day
Anticipated trial start date - 2026 Year 10 Month 16 Day
Last follow-up date - 2026 Year 11 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072402
Disclaimer: Curated by HT Syndication.
